Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Inogen Announces Fourth Quarter and Full Year 2022 Financial Results
Inogen Announces Fourth Quarter and Full Year 2022 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the

Inogen to Provide Strategy Update on February 27, 2023
Inogen to Provide Strategy Update on February 27, 2023


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will host a conference call on Monday

Chemed Reports Fourth-Quarter 2022 Results
Chemed Reports Fourth-Quarter 2022 Results


Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

Dexcom Announces Upcoming Conference Presentations
Dexcom Announces Upcoming Conference Presentations


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:




  • Sean Christensen, Vice President, Finance and

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Agilent Announces Cash Dividend of 22.5 Cents Per Share
Agilent Announces Cash Dividend of 22.5 Cents Per Share


Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 22.5 cents per share of common stock will be paid on April 26, 2023, to all shareholders of record as of the close of

Agilent Inspires at SLAS2023, Highlighting Innovative Automated Workflow Solutions:
Agilent Inspires at SLAS2023, Highlighting Innovative Automated Workflow Solutions


Agilent Technologies Inc. (NYSE: A) announced today that it will highlight a suite of automated laboratory workflow solutions at the SLAS2023 International Conference and Exhibition held February

Premier Inc. Acquires 100 Top Hospitals® Program
Premier Inc. Acquires 100 Top Hospitals® Program


Premier Inc. (NASDAQ: PINC) acquired the 100 Top Hospitals® program from Merative (formerly IBM Watson Health). The program will be integrated within PINC AI, Premier’s technology and services

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
LivaNova Reports Fourth-Quarter and Full-Year 2022 Results
LivaNova Reports Fourth-Quarter and Full-Year 2022 Results


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2022 and issued guidance for 2023.

Dexcom stellt Genauigkeit, Unkompliziertheit und Konnektivität des CGM-Portfolios auf der ATTD Conference in den Blickpunkt, da Zugang zu CGM weltweit zunimmt
Dexcom stellt Genauigkeit, Unkompliziertheit und Konnektivität des CGM-Portfolios auf der ATTD Conference in den Blickpunkt, da Zugang zu CGM weltweit zunimmt


DexCom, Inc. (NASDAQ: DXCM), der weltweit führende Anbieter im Bereich der kontinuierlichen Blutzuckermessung (CGM) in Echtzeit für Menschen mit Diabetes mellitus, wird die Leistungskraft seines

Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally
Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase the strength of its CGM portfolio and unveil new clinical and

STAAR Surgical Reports Fourth Quarter and Fiscal Year 2022 Results
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2022 Results


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the fourth quarter and fiscal year

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Chemed Corporation Declares Quarterly Dividend of 38 Cents
Chemed Corporation Declares Quarterly Dividend of 38 Cents


Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 38-cents per share on the Company’s capital stock, payable on March 17, 2023, to

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Information on Document Availability
Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models
Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced it has entered a new collaboration

QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Premier’s PINC AI™ Receives 2023 Best in KLAS Award for Value-Based Care Consulting
Premier’s PINC AI™ Receives 2023 Best in KLAS Award for Value-Based Care Consulting


PINC AI™, the technology and services platform of Premier Inc. (NASDAQ: PINC), a leading healthcare improvement and technology company, has been awarded the 2023 Best in KLAS designation for

NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023
NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report fourth quarter and

Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2022 Earnings Release
Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2022 Earnings Release


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2022 results on Monday, February 27, 2023, after the close of the market. Acadia